XGN
EXAGEN INC.
Key Financials
Net Income
$-19951000
↓ 32.0%
Operating Income
$-14070000
↓ 3.2%
Total Assets
$58.0M
↑ 29.8%
Total Liabilities
$40.6M
↑ 15.4%
Gross Profit
$38.8M
↑ 17.2%
Shareholders' Equity
$17.4M
↑ 82.9%
Cash & Equivalents
$32.2M
↑ 46.2%
Long-term Debt
$22.9M
↑ 13.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 6/22/2026 | View on SEC |
| 4 | 6/22/2026 | View on SEC |
| 4 | 6/22/2026 | View on SEC |
| 8-K | 6/9/2026 | View on SEC |
| SCHEDULE 13G | 5/27/2026 | View on SEC |
| SCHEDULE 13G/A | 5/20/2026 | View on SEC |
| S-8 | 5/12/2026 | View on SEC |
| 10-Q | 5/11/2026 | View on SEC |
| 8-K | 5/11/2026 | View on SEC |
| ARS | 4/27/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | XGN |
| Company Name | EXAGEN INC. |
| CIK | 1274737 |
| Sector | Services-Medical Laboratories |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 8071 |
| SIC Description | Services-Medical Laboratories |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (760) 560-1501 |